Skip to main content

Table 2 Effect of agaro-oligosaccharides on MDA activity in different organs of CCl4 induced rats a

From: Antioxidant activity and hepatoprotective potential of agaro-oligosaccharides in vitro and in vivo

Groups Liver (nmol/mg prot) Heart (nmol/mg prot) Serum (nmol/ml)
Normal control 2.75 ± 0.51 0.56 ± 0.08 4.20 ± 0.22
CCl4 control 4.62 ± 0.77# 0.68 ± 0.05 4.44 ± 0.64
Vitamin C 2.59 ± 0.02* 0.67 ± 0.11 3.53 ± 0.74
G4 (200 mg/kg) 3.45 ± 0.77 0.54 ± 0.11 3.33 ± 0.11
G5 (400 mg/kg) 2.71 ± 0.18* 0.53 ± 0.14 3.36 ± 0.63
G6 (600 mg/kg) 2.99 ± 0.47 0.45 ± 0.02 2.82 ± 0.66
  1. a n = 8. Each value represents the mean ± SD.
  2. Significant values: *P < 0.05 (vs CCl4 group); #P < 0.05 (vs Normal group).
  3. G4, G5 and G6: group 4, 5, 6 which administrated with sample of 200 mg/kg, 400 mg/kg and 600 mg/kg, respectively.